STAT3 promotes the proliferation and migration of hepatocellular carcinoma cells by regulating AKT2

Xie,Yi; Li,Jianmin; Zhang,Chao

doi:10.3892/ol.2017.7681

STAT3 promotes the proliferation and migration of hepatocellular carcinoma cells by regulating AKT2

Authors:
- Yi Xie
- Jianmin Li
- Chao Zhang
View Affiliations

Affiliations: Department of Endoscopic Treatment and Research Center, People Hospital of Henan Zhengzhou, Zhengzhou, Henan 450003, P.R. China
Published online on: December 21, 2017 https://doi.org/10.3892/ol.2017.7681
Pages: 3333-3338

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The aim of the present study was to investigate the correlation of STAT3 and AKT in HCC cells. HCC cells were transfected with si‑STAT3 and si‑AKT2 in vitro and the mRNA expression of STAT3 and AKT was detected by RT‑PCR, and the protein expression was measured by western blot. MTT assays were used to evaluate cell proliferation, and Transwell assays were performed to detect the ability of migration and invasion. The relationship between STAT3 and AKT was analyzed by ChIP and Dual‑luciferase reporter (DLR) assays. A nude mice experiment was used to verify the correlation. In the present study, we found that the expression of p‑AKT2 and its downstream molecules were reduced in HCC cells transfected with si‑STAT3, and the expression of p‑STAT3 and its downstream molecules was decreased in HCC cells transfected with si‑AKT2. Moreover, the ability of HCC cells proliferation, migration and invasion was decreased in si‑STAT3 transfection group, but AKT2 reversed the role of si‑STAT3 in HCC cells. The ChIP experiment found that STAT3 could bind to the AKT2 promoter in HCC cells. The DLR assay showed that the luciferase activity of AKT2 promoter was enhanced in HCC cells treated by IL‑6. The nude mice experiment found that the tumor grew slowly after transfection with the STAT3‑siRNA lentiviral vector, while AKT2 reversed the effect. STAT3 and AKT2 had mutual regulatory relationship, and STAT3 promoted the occurrence and development of HCC by regulating AKT2.

View Figures

View References

1	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
2	Huang J, Wang Y, Guo Y and Sun S: Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology. 52:60–70. 2010. View Article : Google Scholar : PubMed/NCBI
3	Feitelson MA, Sun B, Satiroglu Tufan NL, Liu J, Pan J and Lian Z: Genetic mechanisms of hepatocarcinogenesis. Oncogene. 21:2593–2604. 2002. View Article : Google Scholar : PubMed/NCBI
4	Hou J, Zhou Y, Zheng Y, Fan J, Zhou W, Ng IO, Sun H, Qin L, Qiu S, Lee JM, et al: Hepatic RIG-I predicts survival and interferon-α therapeutic response in hepatocellular carcinoma. Cancer Cell. 25:49–63. 2014. View Article : Google Scholar : PubMed/NCBI
5	Darnell JE Jr: STATs and gene regulation. Science. 277:1630–1635. 1997. View Article : Google Scholar : PubMed/NCBI
6	Yuen JW, Poon LS, Chan AS, Yu FW, Lo RK and Wong YH: Activation of STAT3 by specific galpha subunits and multiple gbetagamma dimers. Int J Biochem Cell Biol. 42:1052–1059. 2010. View Article : Google Scholar : PubMed/NCBI
7	Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG and Zhang H: Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3. Clin Cancer Res. 12:7140–7148. 2006. View Article : Google Scholar : PubMed/NCBI
8	Levy DE and Darnell JE Jr: Stats: Transcriptional control and biological impact. Nat Rev Mol Cell Biol. 3:651–662. 2002. View Article : Google Scholar : PubMed/NCBI
9	Yang J, Cai X, Lu W, Hu C, Xu X, Yu Q and Cao P: Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells. Cancer Lett. 328:243–251. 2013. View Article : Google Scholar : PubMed/NCBI
10	Pham NA, Tsao MS, Cao P and Hedley DW: Dissociation of gemcitabine sensitivity and protein kinase B signaling in pancreatic ductal adenocarcinoma models. Pancreas. 35:e16–e26. 2007. View Article : Google Scholar : PubMed/NCBI
11	Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, Danino M, Karlan BY and Slamon DJ: Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion and metastasis of human breast and ovarian cancer cells. Cancer Res. 63:196–206. 2003.PubMed/NCBI
12	Lee H, Herrmann A, Deng JH, Kujawski M, Niu G, Li Z, Forman S, Jove R, Pardoll DM and Yu H: Persistently activated Stat3 maintains constitutive NF-κB activity in tumors. Cancer Cell. 15:283–293. 2009. View Article : Google Scholar : PubMed/NCBI
13	Sansone P and Bromberg J: Targeting the interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol. 30:1005–1014. 2012. View Article : Google Scholar : PubMed/NCBI
14	Fukuda A, Wang SC, Morris JP IV, Folias AE, Liou A, Kim GE, Akira S, Boucher KM, Firpo MA, Mulvihill SJ and Hebrok M: Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progression. Cancer Cell. 19:441–455. 2011. View Article : Google Scholar : PubMed/NCBI
15	Kortylewski M, Xin H, Kujawski M, Lee H, Liu Y, Harris T, Drake C, Pardoll D and Yu H: Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment. Cancer Cell. 15:114–123. 2009. View Article : Google Scholar : PubMed/NCBI
16	Lesina M, Kurkowski MU, Ludes K, Rose-John S, Treiber M, Klöppel G, Yoshimura A, Reindl W, Sipos B, Akira S, et al: Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell. 19:456–469. 2011. View Article : Google Scholar : PubMed/NCBI
17	Li N, Grivennikov SI and Karin M: The unholy trinity: Inflammation, cytokines and STAT3 shape the cancer microenvironment. Cancer Cell. 19:429–431. 2011. View Article : Google Scholar : PubMed/NCBI
18	Li GH, Wei H, Lv SQ, Ji H and Wang DL: Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells. Int J Oncol. 37:103–110. 2010.PubMed/NCBI
19	Kunigal S, Lakka SS, Sodadasu PK, Estes N and Rao JS: Stat3-siRNA induces fas-mediated apoptosis in vitro and in vivo in breast cancer. Int J Oncol. 34:1209–1220. 2009.PubMed/NCBI
20	Rössig L, Jadidi AS, Urbich C, Badorff C, Zeiher AM and Dimmeler S: Akt-dependent phosphorylation of p21Cip1 regulates PCNA binding and proliferation of endothelial cells. Mol Cell Biol. 21:5644–5657. 2001. View Article : Google Scholar : PubMed/NCBI
21	Shah A, Swain WA, Richardson D, Edwards J, Stewart DJ, Richardson CM, Swinson DE, Patel D, Jones JL and O'Byrne KJ: Phospho-akt expression is associated with a favorable outcome in non-small cell lung cancer. Clin Cancer Res. 11:2930–2936. 2005. View Article : Google Scholar : PubMed/NCBI
22	Barderas R, Mendes M, Torres S, Bartolomé RA, López-Lucendo M, Villar-Vázquez R, Peláez-García A, Fuente E, Bonilla F and Casal JI: In-depth characterization of the secretome of colorectal cancer metastatic cells identifies key proteins in cell adhesion, migration and invasion. Mol Cell Proteomics. 12:1602–1620. 2013. View Article : Google Scholar : PubMed/NCBI